Lilly announces departure of Anat Ashkenazi, chief financial officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500, Dow rise on Mideast deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Eli Lilly (LLY) PT Raised to $957 at Jefferies
June 6, 2024 4:27 PM EDTJefferies analyst Akash Tewari raised the price target on Eli Lilly (NYSE: LLY) to $957.00 (from $925.00) while maintaining a Buy rating.
The analyst comments "Dona's Ad Com documents look fine we note 1) FDA didn't agree w/ LLY on changing primary endpoint but believes data supports... More
